文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

糖皮质激素对小鼠肺炎链球菌肺炎的生物学效应及转化意义

Biological effects of corticosteroids on pneumococcal pneumonia in Mice-translational significance.
PubMed 文献 · Crit Care · 2024-05-29
一句话结论小鼠模型中地塞米松联合头孢曲松减轻肺炎链球菌肺炎的肺水肿、肺泡蛋白通透性、炎症因子释放、肺损伤评分和低氧血症,且不增加细菌负荷。

该研究在小鼠肺炎链球菌肺炎模型中,给予地塞米松联合头孢曲松,综合进行生理、生化和组织学分析,并与15例机械通气患者(10例肺炎链球菌肺炎、5例对照)的下呼吸道基因表达进行对比。结果显示,联合治疗减少肺水肿形成、肺泡蛋白通透性、促炎细胞因子释放、肺损伤组织病理评分和低氧血症,且不增加细菌负荷。转录组分析发现类固醇治疗在小鼠中的效应也可见于临床样本。作者认为,这些研究为糖皮质激素在肺炎链球菌社区获得性肺炎患者中获益的机制提供了证据。

要点

  • 小鼠肺炎链球菌肺炎模型中,地塞米松联合头孢曲松减少肺水肿形成、肺泡蛋白通透性、促炎细胞因子释放、组织病理肺损伤评分和低氧血症,且不增加细菌负荷。
  • 转录组分析显示,类固醇治疗在小鼠中的效应也可见于临床样本,提示小鼠模型复制了肺炎链球菌肺炎患者的部分特征。
  • 临床样本来自15例机械通气患者(10例肺炎链球菌肺炎、5例对照)的下呼吸道基因表达,与小鼠转录组研究进行比较。
  • 作者认为,这些研究为糖皮质激素在肺炎链球菌社区获得性肺炎患者中获益的机制提供了证据。

适用人群与场景

  • 小鼠肺炎链球菌肺炎模型;临床样本来自15例机械通气患者(10例肺炎链球菌肺炎和5例对照)的下呼吸道基因表达

处置流程与药物剂量

  • 在小鼠中,地塞米松与头孢曲松联合使用;原文未给出地塞米松和头孢曲松的具体剂量、给药途径、频次或疗程

研究设计与关键结果

  • 研究类型:动物实验(小鼠模型)及临床样本转录组分析;样本量:小鼠数量原文未报告,临床样本15例(10例肺炎链球菌肺炎和5例对照)。
  • 在肺炎小鼠中,地塞米松联合头孢曲松减少(1)肺水肿形成、(2)肺泡蛋白通透性、(3)促炎细胞因子释放、(4)组织病理肺损伤评分和(5)低氧血症,但不增加细菌负荷。
  • 转录组分析识别出类固醇治疗在小鼠中的效应,这些效应也在临床样本中观察到。
  • 临床样本的转录组研究提示,小鼠模型复制了肺炎链球菌肺炎患者及类固醇治疗的部分特征。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)及临床样本转录组分析;原文未给出证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些研究为糖皮质激素在肺炎链球菌社区获得性肺炎患者中获益的机制提供了证据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Streptococcus pneumoniae is the most common bacterial cause of community acquired pneumonia and the acute respiratory distress syndrome (ARDS). Some clinical trials have demonstrated a beneficial effect of corticosteroid therapy in community acquired pneumonia, COVID-19, and ARDS, but the mechanisms of this benefit remain unclear. The primary objective of this study was to investigate the effects of corticosteroids on the pulmonary biology of pneumococcal pneumonia in a mouse model. A secondary objective was to identify shared transcriptomic features of pneumococcal pneumonia and steroid treatment in the mouse model and clinical samples.

METHODS: We carried out comprehensive physiologic, biochemical, and histological analyses in mice to identify the mechanisms of lung injury in Streptococcus pneumoniae with and without adjunctive steroid therapy. We also studied lower respiratory tract gene expression from a cohort of 15 mechanically ventilated patients (10 with Streptococcus pneumoniae and 5 controls) to compare with the transcriptional studies in the mice.

RESULTS: In mice with pneumonia, dexamethasone in combination with ceftriaxone reduced (1) pulmonary edema formation, (2) alveolar protein permeability, (3) proinflammatory cytokine release, (4) histopathologic lung injury score, and (5) hypoxemia but did not increase bacterial burden. Transcriptomic analyses identified effects of steroid therapy in mice that were also observed in the clinical samples.

CONCLUSIONS: In combination with appropriate antibiotic therapy in mice, treatment of pneumococcal pneumonia with steroid therapy reduced hypoxemia, pulmonary edema, lung permeability, and histologic criteria of lung injury, and also altered inflammatory responses at the protein and gene expression level. The transcriptional studies in patients suggest that the mouse model replicates some of the features of pneumonia in patients with Streptococcus pneumoniae and steroid treatment. Overall, these studies provide evidence for the mechanisms that may explain the beneficial effects of glucocorticoid therapy in patients with community acquired pneumonia from Streptococcus Pneumoniae.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Taenaka H, Wick KD, Sarma A, et al. Biological effects of corticosteroids on pneumococcal pneumonia in Mice-translational significance. Crit Care. 2024. PMID: 38807178. doi:10.1186/s13054-024-04956-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。